Bridge Pharmaceuticals Ltd.

Bridge Pharmaceuticals Ltd. is a Bangladesh-based animal health pharmaceutical company operating from West Tangra, Sarulia, Demra, Dhaka. Founded in 2010, it focuses on veterinary and aquaculture medicines, nutritional supplements, and biosecurity solutions for livestock, poultry, aquaculture, and companion animals.

What they manufacture

The company offers veterinary therapeutic products covering antibiotics, anti-protozoal formulations, anthelmintic medicines, anti-parasitic solutions, and products intended for disease prevention and treatment. Its nutritional portfolio includes multivitamins, probiotics, amino acids, and multiminerals, while its aquaculture solutions include biosecurity products, pond management solutions, and water quality improvement systems.

These product areas are designed for animal health and food-production settings, serving farmers, veterinarians, livestock and poultry operations, aquaculture producers, and related supply channels. Its stated focus on affordability, product quality, farmer support, and research-driven solutions forms part of its operating approach.

What an Allopathic licence covers

For Bridge Pharmaceuticals, the DGDA register records the licence category as Allopathic. This category identifies the medicine-manufacturing licence associated with the registered premises; the specific dosage forms and products a manufacturer may produce depend on the approvals applicable to that facility and its products.

For procurement, the registered category and status provide a regulatory reference when evaluating a manufacturer. Buyers sourcing medicines or related health products should match the intended product with the applicable regulatory approval rather than assuming that every dosage form or product type is covered simply by the company-level category.

What its DGDA status means

The DGDA register status for this manufacturer is Functional. In practical terms, Functional indicates that the registered manufacturing licence and premises are recorded as operational in the register, making the status relevant when pharmacies, institutions, distributors, and other buyers assess a manufacturer for sourcing.

DGDA status is separate from a product's individual approval. Procurement decisions should therefore consider the relevant product registration or approval alongside the manufacturer's licence category and current status.

Registration and licensing

• DGDA status: Functional
• Licence categories: Allopathic
• DGDA registered address: West Tangra, Sarulia, Demra, Dhaka
• Established: 2010

Product portfolio

• Therapeutics: Antibiotics, anti-protozoal formulations, anthelmintic medicines, anti-parasitic solutions, and disease prevention and treatment products
• Nutritional supplements: Multivitamins, probiotics, amino acids, and multiminerals
• Aquaculture solutions: Biosecurity products, pond management solutions, and water quality improvement systems